Vor Biopharma Inc. · NASDAQ:VOR
Ra Capital Management, L.P. sold 737,989 Vor Biopharma Inc. shares (Form 4)
Traded Apr 13 to Apr 15, 2026 · Filed Apr 15, 2026
From Apr 13 to Apr 15, 2026, Ra Capital Management, L.P. (Director, 10% owner) sold 737,989 Vor Biopharma Inc. shares at an average US$16.10 for US$11.9M, leaving 3,197,619 shares. Filed Apr 15, 2026 (Form 4).
- Sold
- 737,989 shares
- Price
- US$16.10 average (US$15.97 to US$16.15)
- Value
- US$11.9M
- Holding after
- 3,197,619 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 13, 2026 | Common Stock | Sale | 530,610 | US$16.15 | 3,404,998 | Indirect |
| Apr 14, 2026 | Common Stock | Sale | 153,735 | US$15.97 | 3,251,263 | Indirect |
| Apr 15, 2026 | Common Stock | Sale | 53,644 | US$16.01 | 3,197,619 | Indirect |
Source
Related
- Vor Biopharma Inc.
- Ra Capital Management, L.P.
- Vor Biopharma Inc. shareholders
- Form 4 · Ra Capital Management, L.P. · Oct 5, 2026
- Form 4 · Ra Capital Management, L.P. · Apr 21, 2026
- Form 4 · RA Capital Healthcare Fund LP · Aug 26, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Verve Capital Limited · Aug 13, 2026
- Schedule 13G/A · FMR LLC · Aug 7, 2026